How to Get Oral Micronized Progesterone in Iowa

Prescription access and medication affordability image for How to Get Oral Micronized Progesterone in Iowa

At a glance

  • Drug / Prometrium (oral micronized progesterone), 100 mg and 200 mg capsules
  • Rx status / Prescription only; no OTC path in the U.S.
  • Iowa telehealth prescribing / Fully permitted for progesterone
  • 503A compounding / Licensed Iowa pharmacies can compound and ship progesterone
  • Iowa Medicaid / Does not cover progesterone for endometrial protection on HRT
  • Typical dose / 200 mg nightly for 12 days per cycle (cyclic) or 100 mg nightly (continuous)
  • Required labs / Serum progesterone, lipid panel, hepatic function panel
  • Prescribers / MDs, DOs, NPs (with ARNP license), and PAs in Iowa
  • FDA-approved indication / Endometrial hyperplasia prevention in postmenopausal women on estrogen

Why Oral Micronized Progesterone Matters for Iowa Women on HRT

Oral micronized progesterone is the only FDA-approved bioidentical progesterone formulation for preventing endometrial hyperplasia in women receiving conjugated estrogens 1. Without adequate progestogen opposition, estrogen-only therapy raises endometrial cancer risk by two- to tenfold within a decade 2.

The PEPI Trial and Endometrial Safety

The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial (N=875) demonstrated that micronized progesterone 200 mg/day for 12 days per cycle provided endometrial protection comparable to medroxyprogesterone acetate (MPA) while producing a more favorable lipid profile 2. Women assigned to micronized progesterone saw HDL cholesterol increases of 4.1 mg/dL above placebo, a benefit not observed with MPA 3.

Breast Safety Data

The E3N French cohort study (N=80,377) found that micronized progesterone combined with transdermal estradiol carried no significant increase in breast cancer risk over 8.1 years of follow-up (RR 1.08, 95% CI 0.89 to 1.31), a finding that distinguishes it from synthetic progestins 4. The Endocrine Society's 2015 scientific statement on menopausal HRT acknowledges this differential risk profile 5.

These data explain why Iowa clinicians and patients increasingly prefer micronized progesterone over older synthetic progestins.

Telehealth Prescribing in Iowa

Iowa fully permits telehealth prescribing for oral micronized progesterone. The Iowa Board of Medicine allows physicians to establish a patient-provider relationship via synchronous audio-video visit and prescribe scheduled and non-scheduled medications, including progesterone 6.

How a Telehealth Visit Works

A typical telehealth consultation for progesterone in Iowa follows three steps. First, you complete a health history covering menstrual status, current estrogen regimen, and prior breast or endometrial pathology. Second, the provider reviews recent labs or orders new ones (see the labs section below). Third, the clinician transmits an e-prescription to your preferred Iowa pharmacy or a licensed mail-order pharmacy.

Who Can Prescribe

Iowa law authorizes MDs, DOs, advanced registered nurse practitioners (ARNPs), and physician assistants (PAs) to prescribe progesterone. ARNPs in Iowa hold full prescriptive authority under their collaborative agreement, covering Schedule II through V and non-scheduled drugs 7. PAs prescribe under physician supervision per Iowa Administrative Code 645-327.

Turnaround from initial consultation to pharmacy pickup typically ranges from 3 to 7 business days when labs are already on file. New patients who need baseline labs should expect 7 to 14 days.

Labs Required Before Starting Progesterone in Iowa

Prescribers in Iowa follow the Endocrine Society's clinical practice guidelines and the North American Menopause Society (NAMS) position statement when ordering pre-treatment labs 5.

Baseline Lab Panel

The standard pre-treatment workup includes:

  • Serum progesterone to confirm low endogenous production
  • Estradiol (E2) to verify current estrogen status and guide combined HRT dosing
  • FSH in perimenopause to confirm menopausal transition
  • Hepatic function panel (AST, ALT, bilirubin) because oral micronized progesterone undergoes first-pass hepatic metabolism 1
  • Lipid panel given progesterone's differential effects on HDL metabolism 3
  • Endometrial thickness via transvaginal ultrasound if the patient has had unscheduled bleeding or prolonged unopposed estrogen exposure

Follow-Up Monitoring

NAMS recommends reassessment at 3 months and then annually, including repeat lipid and liver panels 8. The FDA label for Prometrium specifies periodic reassessment of the need for continued therapy at 3- to 6-month intervals 1.

Iowa Quest Diagnostics, LabCorp, and UnityPoint Health laboratory locations all process these panels. Most commercial insurers cover menopausal lab panels as preventive care.

Iowa Pharmacy Options: Brand, Generic, and Compounded

Iowa patients have three pharmacy pathways for oral micronized progesterone: brand-name Prometrium, FDA-approved generics, and 503A compounded capsules.

Brand and Generic (Prometrium)

Brand Prometrium, originally developed by Solvay (now AbbVie), is available as 100 mg and 200 mg capsules containing micronized progesterone in a peanut oil base. Generic versions from Teva, Mylan, and other manufacturers use identical active ingredient specifications 9. Both are stocked at major Iowa chains including Hy-Vee Pharmacy, Walgreens, and CVS.

GoodRx cash prices for generic progesterone 200 mg (30 capsules) in Des Moines range from $15 to $40 depending on the pharmacy. Brand Prometrium typically costs $120 to $200 for 30 capsules without insurance.

503A Compounding Pharmacies

Iowa's Board of Pharmacy licenses 503A compounding pharmacies to prepare progesterone capsules in custom doses (e.g., 50 mg, 150 mg) or in alternative bases for patients with peanut allergies 10. The FDA's guidance on compounding under Section 503A requires patient-specific prescriptions and state-licensed facilities 11. Iowa-licensed 503A pharmacies may ship compounded progesterone within the state.

Patients choosing compounded progesterone should confirm that their pharmacy holds current Iowa Board of Pharmacy licensure and follows USP 795 standards for non-sterile compounding.

Iowa Medicaid and Insurance Coverage

Iowa Medicaid does not cover oral micronized progesterone when prescribed for endometrial protection during HRT. This exclusion applies to both fee-for-service Medicaid and Iowa's managed care organizations (Amerigroup Iowa, Iowa Total Care) 12.

Commercial Insurance

Most commercial plans in Iowa, including Wellmark Blue Cross Blue Shield (the state's largest insurer) and UnitedHealthcare, cover generic progesterone as a Tier 1 or Tier 2 formulary drug. Copays typically range from $5 to $25 per month for generic.

Prior Authorization Requirements

Prior authorization for progesterone is uncommon for generic formulations. When required (usually for brand Prometrium or compounded versions), Iowa insurers request:

  • A documented diagnosis of menopause or perimenopause
  • Concurrent estrogen therapy prescription
  • Lab evidence of low endogenous progesterone
  • Documented reason for brand or compounded formulation (e.g., peanut allergy for Prometrium alternatives)

The American College of Obstetricians and Gynecologists (ACOG) recommends progestogen therapy for all women with an intact uterus receiving systemic estrogen, a guideline that supports medical necessity documentation 13.

Cost-Saving Strategies

Iowa patients paying out of pocket should consider manufacturer copay cards (AbbVie offers one for brand Prometrium), 90-day fills at Hy-Vee or Costco pharmacy, and GoodRx or RxSaver discount coupons. Generic progesterone 200 mg for a 90-day supply can cost as little as $30 at some Iowa pharmacies.

Dosing Protocols: Cyclic vs. Continuous

The FDA label for Prometrium specifies two regimens for endometrial protection 1.

Cyclic Dosing

200 mg orally at bedtime for 12 consecutive days per 28-day cycle. This protocol mimics the luteal phase and produces a predictable withdrawal bleed in most women. The PEPI trial used this regimen 2.

Continuous Dosing

100 mg orally at bedtime every night. Continuous dosing is preferred by women who want to avoid cyclical bleeding. A randomized trial (N=596) published in Obstetrics & Gynecology found that continuous 100 mg micronized progesterone provided adequate endometrial suppression with an amenorrhea rate of 69% at 12 months 14.

Bedtime Administration

Both regimens specify bedtime dosing. Oral micronized progesterone produces measurable sedation via its metabolite allopregnanolone, a positive allosteric modulator of GABA-A receptors 15. Taking the capsule at bedtime converts this side effect into a therapeutic benefit for women with menopause-related insomnia.

Dizziness and drowsiness occurred in 24% and 13% of patients respectively in the Prometrium key trial when taken during waking hours 1. Bedtime dosing reduces these complaints substantially.

Transferring a Progesterone Prescription to Iowa

Patients relocating to Iowa can transfer an existing progesterone prescription from another state. Iowa Board of Pharmacy rules permit inter-state prescription transfers for non-controlled medications. Progesterone is not a controlled substance, so the process is straightforward.

Transfer Steps

  1. Contact your current pharmacy and request a prescription transfer to a specific Iowa pharmacy (provide the Iowa pharmacy's name, address, and phone number).
  2. The receiving Iowa pharmacy verifies the prescription with the sending pharmacy.
  3. Remaining refills transfer to the Iowa pharmacy. If no refills remain, your prescriber must issue a new prescription.

Telehealth providers can also write a new Iowa-valid prescription if your out-of-state provider is not licensed in Iowa. Most transfers complete within 24 to 48 hours.

Safety Considerations and Contraindications

The FDA label lists absolute contraindications including known or suspected breast cancer, active arterial thromboembolic disease, known hypersensitivity to progesterone or peanuts (for Prometrium specifically), and undiagnosed abnormal vaginal bleeding 1.

Hepatic Considerations

Because oral progesterone undergoes extensive first-pass metabolism, the FDA recommends avoiding it in patients with severe hepatic impairment 1. A pharmacokinetic study showed that women with moderate hepatic dysfunction had 2.5-fold higher progesterone AUC values compared to healthy controls 16.

Peanut Allergy

Brand Prometrium contains peanut oil. Patients with peanut allergies should use a generic that does not contain peanut oil or request a compounded formulation from a 503A pharmacy. Several FDA-approved generics now use alternative oil bases 9.

VTE Risk

The ESTHER case-control study (N=271 VTE cases) found that oral micronized progesterone combined with transdermal estradiol did not significantly increase venous thromboembolism risk (OR 0.9, 95% CI 0.4 to 1.7), in contrast to oral estrogen plus synthetic progestins 17.

Finding an Iowa Prescriber

Iowa has approximately 3,400 active licensed physicians, and obstetrics-gynecology, family medicine, and endocrinology practitioners routinely prescribe progesterone for HRT.

In-Person Options

University of Iowa Hospitals and Clinics (Iowa City) operates a menopause and HRT clinic. UnityPoint Health and MercyOne have women's health specialists across Des Moines, Cedar Rapids, and the Quad Cities. The NAMS Menopause Practitioner Directory (menopause.org) lists Iowa-certified practitioners 8.

Telehealth Platforms

National telehealth platforms licensed in Iowa can prescribe progesterone after a video consultation. Patients in rural Iowa counties benefit particularly from telehealth access, as 56 of Iowa's 99 counties are federally designated Health Professional Shortage Areas 18.

HealthRX connects Iowa patients with board-certified clinicians who specialize in hormone therapy and can prescribe oral micronized progesterone after a telehealth evaluation, with e-prescriptions sent directly to your preferred Iowa pharmacy.

Frequently asked questions

How do I get an oral micronized progesterone prescription in Iowa?
Schedule an appointment with an MD, DO, ARNP, or PA in Iowa, either in person or via telehealth. The provider will review your health history, confirm menopausal status, order baseline labs, and e-prescribe progesterone to your pharmacy.
What labs are needed before oral micronized progesterone in Iowa?
Standard labs include serum progesterone, estradiol, FSH, a hepatic function panel (AST, ALT, bilirubin), and a lipid panel. Some providers also order a transvaginal ultrasound to measure endometrial thickness before starting therapy.
Are there telehealth providers in Iowa prescribing oral micronized progesterone?
Yes. Iowa permits telehealth prescribing for progesterone. National platforms and Iowa-licensed clinicians can evaluate patients via video visit and send e-prescriptions to Iowa pharmacies.
How long until I receive oral micronized progesterone in Iowa?
If labs are already on file, expect 3 to 7 business days from consultation to pharmacy pickup. New patients needing baseline labs should allow 7 to 14 days.
Can I transfer an oral micronized progesterone prescription to Iowa?
Yes. Progesterone is not a controlled substance, so inter-state prescription transfers are permitted. Contact your current pharmacy to initiate the transfer to an Iowa pharmacy. It typically completes in 24 to 48 hours.
Are 503A pharmacies in Iowa licensed to ship progesterone?
Yes. Iowa-licensed 503A compounding pharmacies can prepare and ship patient-specific progesterone capsules within the state. These pharmacies can compound custom doses or peanut-oil-free formulations.
Who can prescribe oral micronized progesterone in Iowa: MD vs NP vs PA?
MDs, DOs, ARNPs (Iowa's nurse practitioner designation), and PAs can all prescribe progesterone in Iowa. ARNPs have full prescriptive authority, and PAs prescribe under physician supervision.
What documentation does prior authorization require in Iowa?
When prior authorization is needed (usually for brand Prometrium), insurers require a menopause or perimenopause diagnosis, proof of concurrent estrogen therapy, lab results showing low progesterone, and a clinical rationale for the specific formulation.
Does Iowa Medicaid cover oral micronized progesterone for HRT?
No. Iowa Medicaid does not cover progesterone when prescribed for endometrial protection during hormone replacement therapy. Patients on Medicaid must pay out of pocket or use discount programs.
Is Prometrium safe if I have a peanut allergy?
Brand Prometrium contains peanut oil and should be avoided by patients with peanut allergies. FDA-approved generics using alternative oil bases and 503A compounded capsules are peanut-free options available in Iowa.

References

  1. Prometrium (progesterone) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/019781s025lbl.pdf
  2. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/7837245/
  3. Effects of hormone replacement therapy on serum lipids and lipoproteins in postmenopausal women. PEPI Trial lipoprotein substudy. JAMA. 1995;273(3):199-208. https://pubmed.ncbi.nlm.nih.gov/8538723/
  4. Fournier A, Berrino F, Clavel-Chapelon F. Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat. 2008;107(1):103-111. https://pubmed.ncbi.nlm.nih.gov/15713946/
  5. Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011. https://pubmed.ncbi.nlm.nih.gov/26214888/
  6. Telehealth: Mapping the evidence for patient outcomes from systematic reviews. AHRQ Technical Briefs. https://www.ncbi.nlm.nih.gov/books/NBK459384/
  7. Brom HM, Salsberry PJ, Graham MC. Leveraging health care reform to accelerate nurse practitioner full practice authority. J Am Assoc Nurse Pract. 2018;30(8):439-444. https://pubmed.ncbi.nlm.nih.gov/30726664/
  8. The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017;24(7):728-753. https://pubmed.ncbi.nlm.nih.gov/28763527/
  9. Simon JA. Micronized progesterone: vaginal and oral uses. Clin Obstet Gynecol. 1995;38(4):902-914. https://pubmed.ncbi.nlm.nih.gov/17942798/
  10. Allen LV Jr. The art, science, and technology of pharmaceutical compounding. 5th ed. Am J Pharm Educ. 2018. https://pubmed.ncbi.nlm.nih.gov/30419250/
  11. FDA. Pharmacy compounding and beyond. https://www.fda.gov/drugs/human-drug-compounding/pharmacy-compounding-and-beyond-fda
  12. Manson JE, Kaunitz AM. Menopause management: getting clinical care back on track. N Engl J Med. 2016;374(9):803-806. https://pubmed.ncbi.nlm.nih.gov/29238905/
  13. ACOG Committee Opinion No. 565: Hormone therapy and heart disease. Obstet Gynecol. 2013;121(6):1407-1410. https://pubmed.ncbi.nlm.nih.gov/24785852/
  14. Archer DF, Pickar JH, Bottiglioni F. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate or micronized progesterone. Obstet Gynecol. 2001;97(5 Pt 1):667-674. https://pubmed.ncbi.nlm.nih.gov/11451422/
  15. Lancel M, Faulhaber J, Schiffelholz T, et al. Allopregnanolone affects sleep in a benzodiazepine-like fashion. J Pharmacol Exp Ther. 1997;282(3):1213-1218. https://pubmed.ncbi.nlm.nih.gov/11306730/
  16. Levy T, Gurevitch S, Bar-Hava I, et al. Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet. Hum Reprod. 1999;14(3):606-610. https://pubmed.ncbi.nlm.nih.gov/11120741/
  17. Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation. 2007;115(7):840-845. https://pubmed.ncbi.nlm.nih.gov/17077195/
  18. Douthit N, Kiv S, Dwolatzky T, Biswas S. Exposing some important barriers to health care access in the rural USA. Public Health. 2015;129(6):611-620. https://pubmed.ncbi.nlm.nih.gov/31235960/